These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22100331)

  • 1. Origin and plasticity of MHC I-associated self peptides.
    de Verteuil D; Granados DP; Thibault P; Perreault C
    Autoimmun Rev; 2012 Jul; 11(9):627-35. PubMed ID: 22100331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells.
    Nitta T; Murata S; Sasaki K; Fujii H; Ripen AM; Ishimaru N; Koyasu S; Tanaka K; Takahama Y
    Immunity; 2010 Jan; 32(1):29-40. PubMed ID: 20045355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The origin and role of MHC class I-associated self-peptides.
    Perreault C
    Prog Mol Biol Transl Sci; 2010; 92():41-60. PubMed ID: 20800814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides.
    Hammer GE; Gonzalez F; James E; Nolla H; Shastri N
    Nat Immunol; 2007 Jan; 8(1):101-8. PubMed ID: 17128277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.
    Hammer GE; Gonzalez F; Champsaur M; Cado D; Shastri N
    Nat Immunol; 2006 Jan; 7(1):103-12. PubMed ID: 16299505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
    Wolf BJ; Princiotta MF
    Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard and immunoproteasomes show similar peptide degradation specificities.
    Zanker D; Chen W
    Eur J Immunol; 2014 Dec; 44(12):3500-3. PubMed ID: 25399798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoproteasome: probable role in generating positively selecting peptides.
    Murata S; Takahama Y; Tanaka K
    Curr Opin Immunol; 2008 Apr; 20(2):192-6. PubMed ID: 18403190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell-receptor-like antibodies - generation, function and applications.
    Dahan R; Reiter Y
    Expert Rev Mol Med; 2012 Feb; 14():e6. PubMed ID: 22361332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mRNA translation in direct MHC class I antigen presentation.
    Apcher S; Manoury B; Fåhraeus R
    Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 15. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Qa-1 dependent CD8+ T cell mediated regulatory pathway.
    Jiang H
    Cell Mol Immunol; 2005 Jun; 2(3):161-7. PubMed ID: 16212882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
    Segura E; Villadangos JA
    Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.